UBS Group AG - LIMINAL BIOSCIENCES INC ownership

LIMINAL BIOSCIENCES INC's ticker is LMNL and the CUSIP is 53272L103. A total of 20 filers reported holding LIMINAL BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LIMINAL BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$8032,433
+34657.1%
0.00%
Q3 2022$0
-100.0%
7
-99.9%
0.00%
Q2 2022$4,000
-42.9%
7,654
+4.9%
0.00%
Q1 2022$7,000
+250.0%
7,299
+364.9%
0.00%
Q4 2021$2,0001,570
+22328.6%
0.00%
Q3 2021$0
-100.0%
7
-99.9%
0.00%
Q2 2021$22,0005,632
+80357.1%
0.00%
Q1 2021$07
-74.1%
0.00%
Q4 2020$0
-100.0%
27
-96.6%
0.00%
Q3 2020$9,000804
+7209.1%
0.00%
Q2 2020$0
-100.0%
11
-99.3%
0.00%
Q1 2020$10,0000.0%1,487
+26.8%
0.00%
Q4 2019$10,0001,1730.00%
Other shareholders
LIMINAL BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
BREWIN DOLPHIN LTD 234$00.00%
JPMORGAN CHASE & CO 4$00.00%
Renaissance Technologies 66,400$34,0000.00%
TD Waterhouse Canada Inc. 62$420.00%
ROYAL BANK OF CANADA 18,932$10,0000.00%
UBS Group AG 7,654$4,0000.00%
IFP Advisors, Inc 131$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 391$00.00%
GEODE CAPITAL MANAGEMENT, LLC 22,737$11,0000.00%
View complete list of LIMINAL BIOSCIENCES INC shareholders